| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥363.9B | ¥338.5B | +7.5% |
| Operating Income | ¥11.3B | ¥-5.1B | +320.6% |
| Ordinary Income | ¥6.1B | ¥-8.2B | +175.3% |
| Net Income | ¥8.5B | ¥-10.8B | +178.4% |
| ROE | 4.4% | -5.5% | - |
FY2026 Q3 cumulative results (April-December 2025): Revenue 36.39B yen (YoY +7.5%), Operating Income 1.13B yen (prior period -0.51B yen, turnaround to profitability), Ordinary Income 0.61B yen (prior period -0.82B yen, +175.3%), Net Income 0.85B yen (prior period -1.08B yen, +178.4%). The company achieved a return to operating profitability with revenue growth driven primarily by the China segment. However, gross profit margin remained at 9.8%, indicating persistent margin pressure. The gap between operating income and ordinary income reflects a net non-operating expense burden of 0.52B yen, primarily from interest expenses of 0.45B yen. Extraordinary gains of 0.46B yen, mainly from subsidiary stock sales, contributed to the net income turnaround. The company maintains a conservative dividend policy with an annual dividend of 2.0 yen and a payout ratio of 5.7%.
Revenue increased 2.54B yen (+7.5%) to 36.39B yen, driven by volume expansion in the China segment. China segment sales reached 17.94B yen with press molded parts contributing 17.23B yen and mold sales 0.70B yen. Japan segment sales totaled 14.02B yen, down from 14.22B yen YoY, while Thailand segment sales remained stable at 4.44B yen (vs 4.51B yen prior year). The segment notes indicate the company restructured its reporting segments from four categories (J-MAX, Thailand, Guangzhou, Wuhan) to three geographic segments (Japan, Thailand, China) from the beginning of this fiscal year. Operating income improved significantly by 1.65B yen to 1.13B yen from a loss of 0.51B yen in the prior period, reflecting the operational turnaround. The improvement was achieved despite a gross profit margin of 9.8% and selling, general and administrative expenses of 2.45B yen (6.7% of sales). The operating profit improvement was partially offset by non-operating expenses, particularly interest expense of 0.45B yen, resulting in ordinary income of 0.61B yen. The material gap between ordinary income (0.61B yen) and net income (0.85B yen) is explained by extraordinary income of 0.46B yen, primarily from gains on sales of subsidiary shares. Prior year impairment losses of 1.43B yen in the China segment did not recur in the current period, representing a non-recurring positive factor. This represents a revenue up, profit up pattern with successful operational recovery from prior year losses.
The company operates three geographic segments: Japan, Thailand, and China. Japan segment generated revenue of 14.02B yen with segment profit of 0.61B yen (margin 4.3%). Thailand segment recorded revenue of 4.44B yen with segment profit of 0.10B yen (margin 2.2%), recovering from a segment loss of -0.10B yen in the prior year. China segment achieved revenue of 17.94B yen with segment profit of 0.25B yen (margin 1.4%), a substantial improvement from a segment loss of -1.06B yen in the prior period. The China segment is the largest by revenue share at 49.3%, representing the company's core business. Japan maintains the highest profitability margin at 4.3%, while China and Thailand operate at lower margins below 2.5%. The China segment's turnaround from a 1.06B yen loss to 0.25B yen profit represents the most significant operational improvement, eliminating the 1.43B yen impairment loss recorded in the prior year and achieving positive operating leverage.
[Profitability] ROE 4.3% improved substantially from negative territory in the prior year when net income was -1.08B yen, though remains below the manufacturing industry median of 5.0%. Operating margin 3.1% improved from -1.5% YoY but trails the industry median of 8.3%. Net profit margin 2.3% also improved from negative prior year but remains below the industry median of 6.3%. The low margins reflect persistent cost pressures and limited pricing power. Gross profit margin of 9.8% indicates constrained profitability at the product level. [Cash Quality] Cash and deposits 9.37B yen provide 0.51x coverage of current liabilities at 18.53B yen, indicating limited liquidity buffer. Short-term debt coverage stands at 0.87x with short-term borrowings of 10.79B yen requiring near-term refinancing attention. [Investment Efficiency] Total asset turnover 0.633 times exceeds the industry median of 0.58, demonstrating relatively efficient asset utilization. Accounts receivable turnover period extends to 142 days (DSO warning level), significantly above the industry median of 82.87 days, indicating collection delays that constrain cash conversion. Inventory turnover 97.17 days is better than the industry median of 108.81 days. Work-in-process inventory represents 56.8% of total inventory at 2.63B yen, suggesting production process bottlenecks. [Financial Health] Equity ratio 33.4% is substantially below the industry median of 63.8%, indicating high leverage. Current ratio 108.9% falls well below the industry median of 284%, highlighting constrained liquidity. Short-term liabilities ratio of 58.2% raises refinancing risk concerns. Interest-bearing debt totals 18.54B yen with debt-to-equity ratio of 0.96. Interest coverage ratio of 2.51x indicates limited debt servicing capacity given interest expenses of 0.45B yen against ordinary income of 0.61B yen.
Cash and deposits increased 1.33B yen YoY to 9.37B yen, with the operating profit improvement contributing to cash accumulation despite the capital-intensive nature of the business. Working capital movements show mixed efficiency signals: accounts receivable increased 4.71B yen to 14.16B yen, reflecting the extended DSO of 142 days and indicating slower cash collection that partially offsets operational improvements. Accounts payable increased sharply by 2.45B yen to 8.70B yen (+39.2%), reflecting either increased procurement volumes aligned with production expansion or extended payment terms that provide a source of working capital financing. However, the receivables increase outpaced payables growth, resulting in a net working capital drag. Short-term borrowings of 10.79B yen represent 58.2% of total liabilities, indicating the company maintains significant reliance on short-term credit facilities. Cash coverage of short-term liabilities stands at 0.51x, suggesting adequate but not robust liquidity that warrants monitoring of refinancing arrangements. The balance sheet changes indicate the company is generating positive operating profit but faces working capital efficiency challenges, particularly in receivables management, that limit free cash generation.
Ordinary income of 0.61B yen versus operating income of 1.13B yen shows non-operating net expense of approximately 0.52B yen. This comprises primarily interest expenses of 0.45B yen (7.4% of ordinary income and 1.2% of revenue), indicating significant financial burden from the company's debt structure. Non-operating income was limited at 0.12B yen, including interest and dividend income and foreign exchange gains. The movement from ordinary income of 0.61B yen to net income of 0.85B yen reflects extraordinary income of 0.46B yen, primarily gains on sales of subsidiary shares, representing a material one-time benefit. Prior year impairment losses of 1.43B yen in the China segment were not repeated, representing another non-recurring positive factor. Comprehensive income was negative at -0.30B yen despite positive net income, due to foreign currency translation adjustments of -0.96B yen and valuation differences on available-for-sale securities, indicating unrealized losses that reduce shareholder equity. The earnings quality assessment indicates that while operating profit improvement is genuine and recurring, net income was materially supported by non-recurring gains. The operating cash flow relationship cannot be directly assessed due to unavailable quarterly cash flow statement data, but the extended receivables turnover and significant interest burden suggest that cash-backed earnings quality faces headwinds from working capital inefficiency and financial costs.
Full-year guidance: Revenue 49.0B yen, Operating Income 1.5B yen, Ordinary Income 0.8B yen, Net Income 0.85B yen, with annual dividend of 2.0 yen. Q3 cumulative progress rates against full-year guidance are: Revenue 74.3%, Operating Income 75.6%, Ordinary Income 76.8%, Net Income 97.1%. Progress through Q3 (representing 75% of the fiscal year) shows revenue and operating income tracking in line with the standard progression rate, indicating balanced performance through the first three quarters. However, net income progress at 97.1% significantly exceeds the standard 75% benchmark, reflecting the contribution of extraordinary gains of 0.46B yen recorded in Q3 that may not recur in Q4. The company's guidance assumes revenue growth of +4% YoY for the full year, with operating income returning to sustained profitability at 1.5B yen. The operating income guidance implies Q4 operating income of approximately 0.37B yen, representing a sequential moderation from the Q3 cumulative run rate, suggesting conservative expectations for the final quarter. Ordinary income guidance of 0.8B yen for the full year implies Q4 ordinary income of approximately 0.19B yen, indicating continued interest expense burden. The full-year net income guidance of 0.85B yen matches the Q3 cumulative result, implying near-zero contribution expected from Q4, consistent with the one-time nature of Q3 extraordinary gains.
Annual dividend of 2.0 yen per share is maintained at the same level as prior guidance, comprising interim dividend of 2.0 yen and year-end dividend of 2.0 yen. The payout ratio based on forecasted net income of 0.85B yen is 5.7%, reflecting a highly conservative distribution policy that prioritizes capital retention. No share buyback activities were disclosed in the reporting period. The total shareholder return ratio remains at the payout ratio level of 5.7%. The conservative dividend policy appears sustainable given the low payout ratio, though dividend growth potential is limited unless profitability and financial health improve materially. The company is prioritizing financial flexibility and debt management over aggressive shareholder distributions, consistent with the high leverage position (debt-to-equity 0.96) and refinancing risks associated with short-term borrowings of 10.79B yen. Dividend per share of 2.0 yen represents a yield that depends on share price, but the absolute level and payout ratio indicate minimal commitment to income-oriented investors at this stage of the financial recovery.
Margin compression risk: Gross profit margin of 9.8% and operating margin of 3.1% remain substantially below industry medians, leaving minimal buffer against input cost inflation, competitive pricing pressure, or unfavorable product mix shifts. Any deterioration in raw material costs or failure to pass through price increases could quickly erode profitability.
Production efficiency and inventory risk: Work-in-process inventory constitutes 56.8% of total inventory at 2.63B yen, indicating extended production lead times or process bottlenecks. This concentration increases exposure to obsolescence risk and ties up working capital. Manufacturing yield issues or demand changes could necessitate additional write-downs.
Foreign exchange and overseas operations risk: Comprehensive income of -0.30B yen despite positive net income reflects foreign currency translation losses of -0.96B yen, indicating significant exposure to FX volatility. With China representing 49.3% of segment revenue, the company faces currency risk, geopolitical risk, and regulatory risk in its largest market. Yen appreciation or disruptions to Chinese operations would materially impact consolidated results.
[Industry Position] (Reference - Proprietary Analysis)
J-MAX operates in the manufacturing industry with operations concentrated in automotive press molded components and mold manufacturing across Japan, Thailand, and China. The company's financial profile diverges notably from industry medians in several key dimensions.
Profitability: ROE of 4.3% falls below the industry median of 5.0% (2025-Q3, n=98 companies), and operating margin of 3.1% trails significantly behind the industry median of 8.3%. Net profit margin of 2.3% also underperforms the industry median of 6.3%. This profitability gap reflects the company's competitive positioning challenges and cost structure inefficiencies.
Financial Health: Equity ratio of 33.4% substantially lags the industry median of 63.8%, indicating high leverage relative to sector peers. Current ratio of 108.9% is materially below the industry median of 284%, highlighting liquidity constraints. The company's financial leverage of 2.99x exceeds the industry median of 1.53x, confirming above-average balance sheet risk.
Efficiency: Asset turnover of 0.633x modestly exceeds the industry median of 0.58x, demonstrating relatively effective asset utilization. However, receivables turnover of 142 days significantly exceeds the industry median of 82.87 days, indicating collection efficiency issues. Operating working capital turnover cannot be directly compared without additional disclosure, but the extended receivables cycle suggests working capital management lags industry standards.
Growth: Revenue growth of 7.5% YoY outperforms the industry median of 2.7%, positioning the company above average in top-line expansion. This suggests market share gains or end-market outperformance despite the profitability challenges.
Overall, J-MAX demonstrates above-median revenue growth and asset efficiency but underperforms substantially on profitability, financial health, and working capital metrics compared to manufacturing industry peers.
(Industry: Manufacturing, N=98 companies, Period: 2025-Q3, Source: Proprietary analysis)
Return to operating profitability with persistent margin constraints: J-MAX achieved a significant turnaround from operating loss of -0.51B yen to operating profit of 1.13B yen, demonstrating operational recovery. However, operating margin of 3.1% and gross margin of 9.8% remain well below manufacturing industry benchmarks, indicating the company operates in a structurally low-margin competitive environment with limited pricing power. Sustained profitability improvement will require further cost optimization or value-added product mix enhancement beyond current levels.
Financial structure and refinancing considerations: The balance sheet presents notable leverage and liquidity characteristics requiring attention. Short-term borrowings of 10.79B yen represent 58.2% of current liabilities and 96.9% of cash and deposits, creating near-term refinancing requirements. Interest coverage of 2.51x and interest expenses consuming 73.8% of ordinary income indicate constrained debt servicing capacity. The company's ability to extend debt maturities or improve operating cash generation will be critical to financial stability. Current ratio of 108.9% and equity ratio of 33.4% both fall substantially below industry medians, positioning the company in the lower quartile for financial health metrics.
Working capital management and cash conversion quality: Extended receivables collection period of 142 days, significantly above the industry median of 83 days, indicates working capital inefficiency that constrains cash generation despite operating profit improvement. Work-in-process inventory representing 56.8% of total inventory suggests production process optimization opportunities. The 39.2% increase in accounts payable may reflect improved supplier terms but warrants monitoring for sustainability. Addressing receivables collection and production efficiency would enhance free cash flow generation capacity and reduce reliance on external financing.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.